Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Aligos Therapeutics, Inc. has filed 345 SEC EDGAR filings since 16 Jan 2020

SEC filing history

Showing 126-150 of 345 matching filings.

Per page
25
Current page
6
4

4 filing

Filing date
28 Feb 2024
Reporting date
27 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Feb 2024
Reporting date
27 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Feb 2024
Reporting date
27 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Feb 2024
Reporting date
27 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Feb 2024
Reporting date
27 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Feb 2024
Reporting date
27 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Feb 2024
Reporting date
27 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Feb 2024
Reporting date
27 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Feb 2024
Reporting date
27 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-I/A File 005-91770

SC TO-I/A

Filing date
28 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91770

SC 13G/A filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91770

ALIGOS THERAPEUTICS, INC.

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91770

SC 13G/A

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91770

AMENDMENT NO. 2

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91770

SC 13G filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91770

SC 13G filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91770

SC 13D/A

Filing date
08 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-I File 005-91770

SC TO-I

Filing date
30 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C File 005-91770

SC TO-C

Filing date
25 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-275636

424B3

Filing date
28 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-275636

EFFECT filing

Filing date
27 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
22 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .